乙撒利酸以PGE2依赖的方式加剧过敏反应
Philipp Globig1, Payam Morakabati1, Veronika Höfer1
1Division of Allergy and Immunology, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
The Journal of clinical investigation
|March 3, 2025
概括
乙盐酸 (ASA) 通过降低前列腺素E2 (PGE2) 水平,使过敏反应恶化. 恢复PGE2或使用EP受体激动剂可以防止这种效应,突出潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 过敏研究 研究过敏
背景情况:
- 众所周知,乙盐酸 (ASA) 有益过敏性作用,但机制尚不清楚.
- 低水平的稳定性前列腺素E2 (PGE2) 与过敏反应有关.
- 了解ASA在过敏反应中的作用对于患者的安全和治疗至关重要.
研究的目的:
- 调查乙撒利酸 (ASA) 的益解药效应是否依赖于前列腺素E2 (PGE2).
- 阐明ASA诱导的过敏反应恶化背后的机制.
- 为了确定管理ASA加重过敏反应的潜在治疗点.
主要方法:
- 评估过敏反应的实验小鼠模型中的ASA效应.
- 分析了大量患有过敏反应的患者数据集.
- 在ASA治疗过敏个体中进行过敏原挑战.
- 使用前列腺素E2稳定剂和前列腺素E受体 (EP) 激动剂.
主要成果:
- 登记册数据显示,随着ASA药物治疗,严重过敏反应的风险增加.
- 在小鼠中,ASA前期治疗加剧了过敏原依赖性过敏反应,但不是由组胺诱导的过敏反应.
- 减少的PGE2水平被确定为ASA诱导恶化的原因.
- 稳定PGE2或使用EP激动剂逆转了ASA的亲亚核反应作用.
- EP2,EP3和EP4受体单独对小鼠的ASA敏感性有所贡献.
- 在过敏患者中,ASA摄入增加了皮肤对过敏原的反应能力,但并没有增加组胺.
- ASA以PGE2依赖的方式增强了巨细胞的刺激能力.
结论:
- 前列腺素E2 (PGE2) 网络在乙盐酸 (ASA) 加重的过敏反应中发挥着关键作用.
- 前列腺素E (EP) 受体是预防或修改过敏反应结果的潜在治疗点.
- 通过减少PGE2,ASA会加剧过敏症,从而增加巨细胞的敏感性.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Adrenergic Agonists: Therapeutic Uses
712
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
712
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
326
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
326
Allergic Drug Reactions
803
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
803
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
523
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
523


